宁波泰斯拓生物

www.testobio.com
  • 本公司产品仅供体外研究使用,不用于临床诊断
首页  /  产品中心  /  进口菌株

产品中心

试剂盒
菌株
质粒
试剂
联系我们  CONTACT US

0574-87917803

testobio@163.com

浙江省宁波市镇海区庄市街道兴庄路9号创e慧谷42号楼B幢401室
最新促销

货号: TS263591

名称: Candida metapsilosis


货号: TS263592

名称: Candida sake


货号: TS131909

名称: HFBCI28


货号: TS131910

名称: Septoria passiflorae Sydow, anamorph


货号: TS131911

名称: Graphium cuneiferum (Berkeley et Broome) Mason et Ellis


货号: TS131912

名称: Streptomyces scabiei (Thaxter) Lambert and Loria


货号: TSTOA0001

名称: Marisediminicola antarctica


货号: TS276951

名称: Real Time PCR EasyTM-Taqman


货号: TS276952

名称: Bacillus subtilis


货号: TS276954

名称: Bacillus subtilis

MCF 10A

货号 TS211517
中文名称 null
适应种属
检测范围
微信小陈 微信小章
在线留言
产品简介
购买须知
产品名称: MCF 10A
商品货号: TS211517
Organism: Homo sapiens, human
Tissue: mammary gland; breast
Cell Type: epithelial
Product Format: frozen
Morphology: epithelial
Culture Properties: adherent
Biosafety Level: 1

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Disease: fibrocystic disease
Age: 36 years
Gender: female
Ethnicity: Caucasian
Applications:
This line is suitable as a transfection host.
Storage Conditions: liquid nitrogen vapor phase
Disclosure: This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC.
Images: Cell Micrograph of TS211517
Derivation:
MCF 10A was derived from adherent cells in the population.
Clinical Data:
36 years
Caucasian
female
Tumorigenic: No
Effects:
No, in immunosuppressed mice
Yes, in semisolid medium
Comments:
The MCF 10A cell line is a non-tumorigenic epithelial cell line.
The cells are positive for epithelial sialomucins, cytokeratins and milk fat globule antigen.
They exhibit three dimensional growth in collagen, and form domes in confluent cultures.
Thus far, the cells have shown no signs of terminal differentiation or senescence.
The line is responsive to insulin, glucocorticoids, cholera enterotoxin, and epidermal growth factor (EGF).
By electron microscopy the cells display characteristics of luminal ductal cells but not of myoepithelial cells.
They also express breast specific antigens as detected by positive reaction with MFA-Breast and MC-5 monoclonal antibodies.
The calcium content of the medium exerts a strong effect on the morphology of the cells.
Complete Growth Medium: The base medium for this cell line (MEBM) along with the additives can be obtained from Lonza/Clonetics Corporation as a kit: MEGM, Kit Catalog No. CC-3150. ATCC does not use the GA-1000 (gentamycin-amphotericin B mix) provided with kit. To make the complete growth medium, you will need to add the following components to the kit (sold separately):
  • 100 ng/ml cholera toxin
Note: Do not filter complete medium
Subculturing:
Remove medium and rinse monolayer with PBS (ATCC® 30-2200™). Add 3.0 mL 0.05% trypsin, 0.53 mM EDTA and incubate at 37°C for 15 minutes. To neutralize trypsin, add 3 mL solution of 0.1% soybean trypsin inhibitor (ATCC® 30-2104™). Centrifuge cell suspension at 125 x g for 5 to 10 minutes. Resuspend cell pellet in complete culture medium. Add appropriate aliquots of cell suspension to new culture vessels.xa0Corning® T-75 flasks (catalog #430641) are recommended for subculturing this product.
Subcultivation Ratio: A subcultivation ratio of 1:3 to 1:4 is recommended
Medium Renewal: Every 2 to 3 days
Cryopreservation:
Freeze medium: Complete growth medium supplemented with 7.5% (v/v) DMSO
Storage temperature: liquid nitrogen vapor phase
Culture Conditions:
Temperature: 37°C
Atmosphere: air, 95%; carbon dioxide (CO2), 5%
STR Profile:
Amelogenin: X
CSF1PO: 10,12
D13S317: 8,9
D16S539: 11,12
D5S818: 10,13
D7S820: 10,11
THO1: 8,9.3
TPOX: 9,11
vWA: 15,17
Isoenzymes:
AK-1, 1
ES-D, 1
G6PD, B
GLO-I, 1-2
PGM1, 1-2
PGM3, 1
Name of Depositor: Michigan Cancer Foundation
Deposited As: Homo sapiens
U.S. Patent Number:
Year of Origin: August 22, 1984
References:

Soule H, McGrath CM. Immortal human mammary epithelial cell lines. US Patent 5,026,637 dated Jun 25 1991

Pauley RJ, et al. Immortal human mammary epithelial cell sublines. US Patent 5,206,165 dated Apr 27 1993

Soule HD, McGrath CM. A simplified method for passage and long-term growth of human mammary epithelial cells. In Vitro Cell. Dev. Biol. 22: 6-12, 1986. PubMed: 2418007

Soule HD, et al. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res. 50: 6075-6086, 1990. PubMed: 1975513

Tait L, et al. Ultrastructural and immunocytochemical characterization of an immortalized human breast epithelial cell line, MCF-10. Cancer Res. 50: 6087-6094, 1990. PubMed: 1697506